Senti Biosciences Holdings, Inc.

Dynamics Special Purpose Corp, trading under the ticker DYNS, was a blank-check company that completed its initial public offering in 2021 with a focus on the life sciences and biotechnology sector. The SPAC filed an 8-K with the SEC on December 20, 2021, accession number 0001193125-21-361732, in connection with its proposed business combination with Senti Biosciences Holdings, Inc., a synthetic biology company developing programmable gene circuit technology for cell and gene therapy applications. The transaction represented a de-SPAC pathway for Senti Biosciences into the public markets. The merger was subsequently completed in 2022, with the combined company operating in the clinical-stage biotechnology space. Sign up for full data on SpacDesk to access complete filing histories, deal timelines, and sponsor analytics for DYNS and hundreds of other SPAC transactions.